Future Fertility announces breakthrough in non-invasive euploid insights

Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights.

This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict which are most likely to develop into euploid blastocysts—embryos with the correct number of chromosomes—during IVF treatment.

By providing these insights early in the process, Euploidy Insights is set to redefine how clinics and patients approach fertility decision-making. 

 Introducing Euploidy Insights 

The AI models powering Euploidy Insights build upon Future Fertility’s current industry-leading MAGENTA™ AI and represent their most advanced technology to date.

Euploidy Insights was developed using their latest scientific research, which has been presented at renowned global conferences like ESHRE 2024.

This breakthrough emphasises the critical connection between egg quality and embryo viability, equipping fertility care teams with deeper personalised insights that: 

• Support more effective, tailored counselling conversations 

• Deliver key data to guide decision-making as treatment progresses toward embryo transfer 

Jullin Fjeldstad, Head of Clinical Embryology at Future Fertility, said: “This is a ground-breaking moment.

“Euploidy Insights gives labs a non-invasive predictive tool to assess an oocyte’s potential, farther along the IVF process than ever before – from egg retrieval through to the likelihood of producing a euploid blastocyst.

“This deeper understanding supports more informed clinical decisions and ultimately better outcomes for patients.” 

Redesigned Reports and Real-Time Predictions for an Enhanced Experience 

Alongside this major innovation, Future Fertility is launching two other enhancements to its widely used VIOLET™ and MAGENTA™ oocyte reports, trusted by over 190 clinics globally.

Both reports will have a new refreshed design, which incorporates feedback from patients, clinicians and embryologists.

These enhancements prioritise user experience and offer:  

• Improved readability and clarity of insights. 

• A modern, clean look that aligns with today’s clinic aesthetics. 

• Larger, high-quality oocyte images to strengthen patient engagement. 

• A new resources section to empower patients with evidence-based guidance. 

 Embryologists using the software will also have the ability to do real-time oocyte predictions directly in the application, unlocking new use cases for lab workflows and egg banks. 

 Christy Prada, CEO, said: “Our refreshed report features are more than just a design update.

“They reflect our commitment to delivering both scientific innovation and an optimised user experience, making insights easier to interpret while enhancing the patient journey.” 

 Elevating Patient Engagement Worldwide  

 Patients across the globe appreciate Future Fertility’s reports for helping them feel more connected to their fertility journeys and better informed in their decision making.

With larger, high-quality oocyte images and deeper personalised, science-backed insights, the new reports provide greater support to patients as they navigate egg freezing and IVF processes.